Delta-like Ligand 3-Directed 225Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer Models.
Saved in:
| Title: | Delta-like Ligand 3-Directed 225Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer Models. |
|---|---|
| Authors: | Hoang TT; Department of Pharmacology, Weill Cornell Graduate School of Medical Sciences, New York, New York.; Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York., Bauer D; Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York., Ingham A; Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York., Miranda IC; Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, and The Rockefeller University, New York, New York., Carter LM; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Michel A; Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York., De Gregorio R; Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York., Welk J; Department of Pharmacology, Weill Cornell Graduate School of Medical Sciences, New York, New York.; Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York., Zhong H; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Poirier JT; Perlmutter Cancer Center, New York University Langone Health, New York, New York; and., Morris MJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Bodei L; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Rudin CM; Department of Pharmacology, Weill Cornell Graduate School of Medical Sciences, New York, New York.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Tendler S; Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Lewis JS; Department of Pharmacology, Weill Cornell Graduate School of Medical Sciences, New York, New York; lewisj2@mskcc.org.; Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 Jun 01; Vol. 67 (6), pp. 943-949. Date of Electronic Publication: 2026 Jun 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1535-5667 |
|---|---|
| DOI: | 10.2967/jnumed.125.271302 |
